Sphingosomal vincristine plus rituximab for treatment of large B-cell lymphoma.

被引：0
|
作者：
Ashcroft, AJ
Kaplan, LD
Damon, LE
Morgan, GJ
机构：
[1] Univ Leeds, Acad Unit Haematol & Oncol, Leeds, W Yorkshire, England
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1454
引用
收藏
页码：400A / 401A
页数：2
相关论文
共 50 条
  • [1] Rituximab plus liposomal vincristine for the treatment of large B-cell lymphoma in the elderly.
    Ashcroft, AJ
    Kaplan, LD
    Damon, LE
    Morgan, GJ
    BLOOD, 2002, 100 (11) : 301B - 301B
  • [2] Cost-effectiveness of rituximab in treatment of diffuse large B-cell lymphoma.
    Coiffier, B
    Best, JH
    Omnes, LF
    Hornberger, JC
    BLOOD, 2001, 98 (11) : 864A - 864A
  • [3] Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar, S
    Maghfoor, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1830 - 1831
  • [4] Fostamatinib for the treatment of diffuse large B-cell lymphoma.
    Arkenau, Hendrik-Tobias
    Patrikidou, Anna
    Flinn, Ian
    Hylton, Jonas C.
    Tong, Sandra
    Ardeshna, Kirit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Rituximab plus CHOP for diffuse large-B-cell lymphoma. Reply
    Coiffier, B
    Gisselbrecht, C
    Reyes, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1831 - 1831
  • [6] Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
    Vitolo, Umberto
    Trneny, Marek
    Belada, David
    Burke, John M.
    Carella, Angelo Michele
    Chua, Neil
    Abrisqueta, Pau
    Demeter, Judit
    Flinn, Ian
    Hong, Xiaonan
    Kim, Won Seog
    Pinto, Antonio
    Shi, Yuan-Kai
    Tatsumi, Yoichi
    Oestergaard, Mikkel Z.
    Wenger, Michael
    Fingerle-Rowson, Gunter
    Catalani, Olivier
    Nielsen, Tina
    Martelli, Maurizio
    Sehn, Laurie H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3529 - +
  • [7] VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly
    Fina, Mariapaola
    Tani, Monica
    Stefoni, Vittorio
    Musuraca, Gerardo
    Marchi, Enrica
    Pellegrini, Cinzia
    Alinari, Lapo
    Derenzini, Enrico
    Bacci, Francesco
    Pileri, Stefano
    Baccarani, Michele
    Zinzani, Pier Luigi
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2167 - 2171
  • [8] Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Burke, John M.
    Masaquel, Anthony
    Wang, Rongrong
    Hossain, Farah
    Li, Jia
    Zhou, Summera Qiheng
    Ng, Carmen D.
    Matasar, Matthew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : e393 - e404
  • [9] Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma
    Hornberger, JC
    Best, JH
    CANCER, 2005, 103 (08) : 1644 - 1651
  • [10] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345